▼ -8.99% Downside Potential
This price target is based on 9 analysts offering 12 month price targets for Acadia Healthcare in the last 3 months. The average price target is $59.80, with a high forecast of $73.00 and a low forecast of $42.00. The average price target represents a -8.99% upside from the last price of $65.71.
The current consensus among 9 investment analysts is to buy stock in Acadia Healthcare. This rating has held steady since December 2020, when it changed from a Hold consensus rating.
Acadia Healthcare Company, Inc. develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities in the United States and Puerto Rico. The company operates acute inpatient psychiatric facilities, which cares to stabilize patients that are either threat to themselves or others by hourly observation, daily intervention, and monitoring by psychiatrists; and specialty treatment facilities, including residential recovery and eating disorder facilities, and comprehensive treatment centers that provide continuum care for adults with addictive disorders and co-occurring mental disorders. It also provides residential treatment centers, which treat patients with behavioral disorders in a non-hospital setting, including outdoor programs; and outpatient community-based services, such as community-based programs that are designed to offer therapeutic treatment to children and adolescents who have a clinically-defined emotional, psychiatric, or chemical dependency disorders. In addition, the company provides education and children's, and adult care services. As of December 31, 2020, it operated a network of 572 behavioral healthcare facilities with approximately 18,100 beds. The company was founded in 2005 and is headquartered in Franklin, Tennessee.